ARTICLE | Clinical News
HTI-501: Interim Phase I/II data
February 13, 2012 8:00 AM UTC
Interim data from the open-label, dose-escalation Phase I portion of a blinded, placebo-controlled, Latin American Phase I/II trial in women with moderate to severe edematous fibrosclerotic panniculop...